Evaluation of the molecular mechanisms underlying the anti-oncological effects of BET bromodomain inhibitor I-BET151 in glioblastoma LN18 cells has revealed the significance of abrogation of hyperactivation of HOTAIR lncRNA (Pastori et al. 2015). This evidence concerns the gene HOTAIR and glioblastoma.